PROVIDER PROFILE · NPI 1023194131

Jing-Wei Huang

OphthalmologySaint Louis, MOI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

920

Beneficiaries

—

Total drug cost

$57K

Distinct drugs

Brand share

30.1%

Top prescribed drugs

Prednisolone Acetate167 claims

Ofloxacin124 claims

Latanoprost82 claims

Brimonidine Tartrate74 claims

Neomycin/Polymyxin B/Dexametha65 claims

QUALITY · MIPS · 2024

Final MIPS score

84.2

Quality

71.6

Cost

75.7

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.39%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Jing-Wei Huang's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 6 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Morey Blinder Hematology · Saint Louis, MO	13	35
ST. LUKES EPISCOPAL-PRESBYTERIAN HOSPITAL	13	34
MISSOURI BAPTIST MEDICAL CENTER	13	23

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
BARNES JEWISH HOSPITAL	80	245
Laboratory Corporation Of America Holdings Clinical Laboratory · Dublin, OH	18	34
Labone Llc Clinical Laboratory · Lenexa, KS	17	31
Morey Blinder Hematology · Saint Louis, MO	12	50
George Harocopos Ophthalmology · Saint Louis, MO	12	39
Adam Dao Ophthalmology · San Diego, CA	12	29

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history